Aveanna Healthcare (NASDAQ:AVAH) Reaches New 1-Year High at $3.24

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) shares hit a new 52-week high during trading on Friday . The company traded as high as $3.24 and last traded at $3.16, with a volume of 113576 shares traded. The stock had previously closed at $2.91.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft boosted their price target on Aveanna Healthcare from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Monday, March 18th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Hold” and an average price target of $1.80.

View Our Latest Stock Analysis on Aveanna Healthcare

Aveanna Healthcare Trading Up 7.2 %

The firm has a market capitalization of $600.22 million, a PE ratio of -5.27 and a beta of 2.07. The business’s 50 day simple moving average is $2.59 and its two-hundred day simple moving average is $2.48.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last announced its earnings results on Thursday, May 9th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. The company had revenue of $490.65 million for the quarter, compared to analysts’ expectations of $485.05 million. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. As a group, equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.13 earnings per share for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. Nut Tree Capital Management LP increased its stake in shares of Aveanna Healthcare by 11.7% in the 4th quarter. Nut Tree Capital Management LP now owns 12,372,649 shares of the company’s stock worth $33,159,000 after purchasing an additional 1,296,045 shares in the last quarter. King Street Capital Management L.P. increased its stake in shares of Aveanna Healthcare by 50.6% in the 4th quarter. King Street Capital Management L.P. now owns 6,400,000 shares of the company’s stock worth $17,152,000 after purchasing an additional 2,150,000 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Aveanna Healthcare by 24.6% in the 4th quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock worth $64,000 after purchasing an additional 4,721 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after purchasing an additional 44,970 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in shares of Aveanna Healthcare by 185.6% in the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after purchasing an additional 19,096 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Read More

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.